Wellington Management Group LLP Has $3.02 Billion Holdings in Stryker Co. (NYSE:SYK)

Wellington Management Group LLP reduced its position in Stryker Co. (NYSE:SYK - Free Report) by 17.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,377,750 shares of the medical technology company's stock after selling 1,716,746 shares during the period. Wellington Management Group LLP owned approximately 2.20% of Stryker worth $3,016,409,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. Kohmann Bosshard Financial Services LLC acquired a new stake in Stryker during the 4th quarter valued at approximately $25,000. Dunhill Financial LLC grew its position in shares of Stryker by 94.9% during the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company's stock worth $27,000 after buying an additional 37 shares in the last quarter. Rakuten Securities Inc. grew its position in shares of Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after buying an additional 68 shares in the last quarter. Centricity Wealth Management LLC bought a new stake in shares of Stryker in the fourth quarter worth $30,000. Finally, BankPlus Trust Department acquired a new stake in Stryker in the fourth quarter valued at $33,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 201,392 shares of the business's stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the sale, the director now directly owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. The trade was a 5.24 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Allan C. Golston sold 2,458 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the transaction, the director now owns 14,895 shares of the company's stock, valued at approximately $5,705,827.65. This trade represents a 14.16 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 5.50% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on SYK shares. Stifel Nicolaus boosted their target price on shares of Stryker from $400.00 to $440.00 and gave the stock a "buy" rating in a research report on Wednesday, January 29th. StockNews.com lowered Stryker from a "buy" rating to a "hold" rating in a research report on Thursday, March 6th. Citigroup reiterated a "buy" rating and issued a $450.00 price target on shares of Stryker in a report on Wednesday, February 26th. Barclays raised their price objective on Stryker from $418.00 to $443.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. Finally, The Goldman Sachs Group set a $422.00 target price on shares of Stryker in a research note on Tuesday, March 4th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $421.90.

Stryker Stock Performance

Shares of NYSE SYK traded down $22.01 during midday trading on Friday, reaching $346.14. 3,956,734 shares of the company traded hands, compared to its average volume of 1,318,651. The stock has a 50-day moving average price of $381.69 and a 200 day moving average price of $374.23. The company has a market cap of $132.12 billion, a price-to-earnings ratio of 44.61, a PEG ratio of 2.93 and a beta of 0.95. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping analysts' consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same period last year, the company posted $3.46 earnings per share. Sell-side analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 0.97%. The ex-dividend date is Monday, March 31st. Stryker's dividend payout ratio (DPR) is presently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.